Cargando…
Development of 3D Printed Biodegradable Mesh with Antimicrobial Properties for Pelvic Organ Prolapse
To address the increasing demand for safe and effective treatment options for pelvic organ prolapse (POP) due to the worldwide ban of the traditional polypropylene meshes, this study introduced degradable polycaprolactone (PCL)/polyethylene glycol (PEG) composite meshes fabricated with melt-electrow...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8877663/ https://www.ncbi.nlm.nih.gov/pubmed/35215676 http://dx.doi.org/10.3390/polym14040763 |
_version_ | 1784658473566339072 |
---|---|
author | Ren, Jiongyu Murray, Rebecca Wong, Cynthia S. Qin, Jilong Chen, Michael Totsika, Makrina Riddell, Andrew D. Warwick, Andrea Rukin, Nicholas Woodruff, Maria A. |
author_facet | Ren, Jiongyu Murray, Rebecca Wong, Cynthia S. Qin, Jilong Chen, Michael Totsika, Makrina Riddell, Andrew D. Warwick, Andrea Rukin, Nicholas Woodruff, Maria A. |
author_sort | Ren, Jiongyu |
collection | PubMed |
description | To address the increasing demand for safe and effective treatment options for pelvic organ prolapse (POP) due to the worldwide ban of the traditional polypropylene meshes, this study introduced degradable polycaprolactone (PCL)/polyethylene glycol (PEG) composite meshes fabricated with melt-electrowriting (MEW). Two PCL/PEG mesh groups: 90:10 and 75:25 (PCL:PEG, wt%) were fabricated and characterized for their degradation rate and mechanical properties, with PCL meshes used as a control. The PCL/PEG composites showed controllable degradation rates by adjusting the PEG content and produced mechanical properties, such as maximal forces, that were higher than PCL alone. The antibacterial properties of the meshes were elicited by coating them with a commonly used antibiotic: azithromycin. Two dosage levels were used for the coating: 0.5 mg and 1 mg per mesh, and both dosage levels were found to be effective in suppressing the growth of S. aureus bacteria. The biocompatibility of the meshes was assessed using human immortalized adipose derived mesenchymal stem cells (hMSC). In vitro assays were used to assess the cell viability (LIVE/DEAD assay), cell metabolic activity (alamarBlue assay) and cell morphology on the meshes (fluorescent and electron microscopy). The cell attachment was found to decrease with increased PEG content. The freshly drug-coated meshes showed signs of cytotoxicity during the cell study process. However, when pre-released for 14 days in phosphate buffered saline, the initial delay in cell attachment on the drug-coated mesh groups showed full recovery at the 14-day cell culture time point. These results indicated that the PCL/PEG meshes with antibiotics coating will be an effective anti-infectious device when first implanted into the patients, and, after about 2 weeks of drug release, the mesh will be supporting cell attachment and proliferation. These meshes demonstrated a potential effective treatment option for POP that may circumvent the issues related to the traditional polypropylene meshes. |
format | Online Article Text |
id | pubmed-8877663 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-88776632022-02-26 Development of 3D Printed Biodegradable Mesh with Antimicrobial Properties for Pelvic Organ Prolapse Ren, Jiongyu Murray, Rebecca Wong, Cynthia S. Qin, Jilong Chen, Michael Totsika, Makrina Riddell, Andrew D. Warwick, Andrea Rukin, Nicholas Woodruff, Maria A. Polymers (Basel) Article To address the increasing demand for safe and effective treatment options for pelvic organ prolapse (POP) due to the worldwide ban of the traditional polypropylene meshes, this study introduced degradable polycaprolactone (PCL)/polyethylene glycol (PEG) composite meshes fabricated with melt-electrowriting (MEW). Two PCL/PEG mesh groups: 90:10 and 75:25 (PCL:PEG, wt%) were fabricated and characterized for their degradation rate and mechanical properties, with PCL meshes used as a control. The PCL/PEG composites showed controllable degradation rates by adjusting the PEG content and produced mechanical properties, such as maximal forces, that were higher than PCL alone. The antibacterial properties of the meshes were elicited by coating them with a commonly used antibiotic: azithromycin. Two dosage levels were used for the coating: 0.5 mg and 1 mg per mesh, and both dosage levels were found to be effective in suppressing the growth of S. aureus bacteria. The biocompatibility of the meshes was assessed using human immortalized adipose derived mesenchymal stem cells (hMSC). In vitro assays were used to assess the cell viability (LIVE/DEAD assay), cell metabolic activity (alamarBlue assay) and cell morphology on the meshes (fluorescent and electron microscopy). The cell attachment was found to decrease with increased PEG content. The freshly drug-coated meshes showed signs of cytotoxicity during the cell study process. However, when pre-released for 14 days in phosphate buffered saline, the initial delay in cell attachment on the drug-coated mesh groups showed full recovery at the 14-day cell culture time point. These results indicated that the PCL/PEG meshes with antibiotics coating will be an effective anti-infectious device when first implanted into the patients, and, after about 2 weeks of drug release, the mesh will be supporting cell attachment and proliferation. These meshes demonstrated a potential effective treatment option for POP that may circumvent the issues related to the traditional polypropylene meshes. MDPI 2022-02-16 /pmc/articles/PMC8877663/ /pubmed/35215676 http://dx.doi.org/10.3390/polym14040763 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Ren, Jiongyu Murray, Rebecca Wong, Cynthia S. Qin, Jilong Chen, Michael Totsika, Makrina Riddell, Andrew D. Warwick, Andrea Rukin, Nicholas Woodruff, Maria A. Development of 3D Printed Biodegradable Mesh with Antimicrobial Properties for Pelvic Organ Prolapse |
title | Development of 3D Printed Biodegradable Mesh with Antimicrobial Properties for Pelvic Organ Prolapse |
title_full | Development of 3D Printed Biodegradable Mesh with Antimicrobial Properties for Pelvic Organ Prolapse |
title_fullStr | Development of 3D Printed Biodegradable Mesh with Antimicrobial Properties for Pelvic Organ Prolapse |
title_full_unstemmed | Development of 3D Printed Biodegradable Mesh with Antimicrobial Properties for Pelvic Organ Prolapse |
title_short | Development of 3D Printed Biodegradable Mesh with Antimicrobial Properties for Pelvic Organ Prolapse |
title_sort | development of 3d printed biodegradable mesh with antimicrobial properties for pelvic organ prolapse |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8877663/ https://www.ncbi.nlm.nih.gov/pubmed/35215676 http://dx.doi.org/10.3390/polym14040763 |
work_keys_str_mv | AT renjiongyu developmentof3dprintedbiodegradablemeshwithantimicrobialpropertiesforpelvicorganprolapse AT murrayrebecca developmentof3dprintedbiodegradablemeshwithantimicrobialpropertiesforpelvicorganprolapse AT wongcynthias developmentof3dprintedbiodegradablemeshwithantimicrobialpropertiesforpelvicorganprolapse AT qinjilong developmentof3dprintedbiodegradablemeshwithantimicrobialpropertiesforpelvicorganprolapse AT chenmichael developmentof3dprintedbiodegradablemeshwithantimicrobialpropertiesforpelvicorganprolapse AT totsikamakrina developmentof3dprintedbiodegradablemeshwithantimicrobialpropertiesforpelvicorganprolapse AT riddellandrewd developmentof3dprintedbiodegradablemeshwithantimicrobialpropertiesforpelvicorganprolapse AT warwickandrea developmentof3dprintedbiodegradablemeshwithantimicrobialpropertiesforpelvicorganprolapse AT rukinnicholas developmentof3dprintedbiodegradablemeshwithantimicrobialpropertiesforpelvicorganprolapse AT woodruffmariaa developmentof3dprintedbiodegradablemeshwithantimicrobialpropertiesforpelvicorganprolapse |